Public Company Global News & Press Release Distribution

Public Company News

All
APAC

HTCO Expands Lithium Resources Transportation Business As It Optimizes Its Strategy and Capital Structure

NEW YORK, April 22, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO, the "Company") today formally announced the strategic expansion into the lithium resources transportation business as a core initiative to optimize cargo mix and strengthen profit resilience. The Company also ...

2026-04-22 21:00 4284

Tuya Filed 2025 Annual Report on Form 20-F and Released Environmental, Social and Governance Report

SANTA CLARA, Calif., April 22, 2026 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities a...

2026-04-22 20:00 3693

Yalla Group Limited Files 2025 Annual Report on Form 20-F

DUBAI, UAE, April 22, 2026 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced that it has filed its annual report on Form 20-F that includes its audited fin...

2026-04-22 19:05 4972

Shinhan Financial Group files its FY2025 Form 20-F to the SEC

SEOUL, South Korea, April 22, 2026 /PRNewswire/ -- Shinhan Financial Group (NYSE: SHG) (KRX: 055550) filed its Annual Report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission (SEC) on April 22, 2026. The report is available at Shinhan Financial Gro...

2026-04-22 19:03 3923

Gaotu Techedu Files Its Annual Report on Form 20-F

BEIJING, April 22, 2026 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company in China focused on enabling lifelong learning through AI-powered solutions, today filed its annual report on Form 20-F for the fiscal year ended Decem...

2026-04-22 18:25 2386

China Automotive Systems Reports Record Earnings Per Share and Net Sales in 2025

WUHAN, China, April 22, 2026 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced its unaudited financial results for the fourth quarter and the audited results for the fiscal ye...

2026-04-22 18:00 6101

New Oriental Announces Results for the Third Fiscal Quarter Ended February 28, 2026

BEIJING, April 22, 2026 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results for the third fiscal quarter ended February 28, 202...

2026-04-22 17:00 4472

Samsung Biologics Reports First Quarter 2026 Financial Results

* Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW 581 billion * Performance driven by full utilization across Plants 1 through 4 and robust operational execution * Strengthened the foundations for future growth through U.S. expansion and strategic partnerships INCHEO...

2026-04-22 14:50 4423

Innovent to Present New Clinical Data of IBI363（PD-1/IL-2α-biased bispecific fusion protein） at the 2026 ASCO Annual Meeting

SAN FRANCISCO and SUZHOU, China, April 21, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...

2026-04-22 08:00 4522

ViGenCell's VT-EBV-N Selected for Oral Presentation at ASCO 2026

Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April 21, 2026 /PRNewswire/ -- ViGenCell Inc. (KOSDAQ: 308080), a clinical-stage biotechnology company based in South Korea focused on advanced cell therapies, today announced that resu...

2026-04-22 07:30 3143

Health In Tech to Present at the Market Movers Investor Summit

STUART, Fla., April 21, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) (the "Company"), an AI-enabled InsurTech platform company, today announced that it will be participating in the Market Movers Investor Summit on Tuesday, May 5, 2026. The Company's presentation, led by Julia Qian, CFO...

2026-04-22 04:00 5065

Massimo Expands Fleet Network and Advances Second-Generation Autonomous Patrol Platform

Growing deployment across facility-based environments and enhanced autonomous capabilities support broader commercial applications GARLAND, Texas, April 21, 2026 /PRNewswire/ -- Massimo Motor today announced the continued expansion of its electric vehicle fleet network across municipal, commerci...

2026-04-21 21:25 6125

Massimo Expands Fleet Network and Advances Second-Generation Autonomous Patrol Platform

EZGO Takes Full Legal Ownership of Its Self-Built Changzhou Manufacturing Facility to Scale Production

CHANGZHOU, China, April 21, 2026 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a short-distance transportation solutions provider in China, today announced that its subsidiary, Jiangsu EZGO New Energy Technology Co., Ltd., has received the real estate ownership ...

2026-04-21 21:15 4433

Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery

CAMBRIDGE, Mass., April 21, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the strategic formation of the industry's first Longevity Board (Board). The initiative provides scienti...

2026-04-21 21:05 5721

Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)

* Seven abstracts accepted for presentation include data from long-term follow-up studies and a post-hoc analysis of the pivotal LIBERTY studies (LIBERTY-CD and LIBERTY-UC) of ZYMFENTRA® (infliximab-dyyb) * Findings emphasize clinical decision-making in long-term management of inflammatory bo...

2026-04-21 20:00 5063

From Molecular Design to Scalable Execution: The Combined Impact of AI and Flow Chemistry

SHANGHAI, April 21, 2026 /PRNewswire/ -- As drug discovery places greater emphasis on practical execution and scalable delivery, flow chemistry is playing an increasingly important role across modern synthesis workflows. At the latest Viva Biotech's series webinar, "AI x Flow Chemistry: From Benc...

2026-04-21 17:57 5037

Seeing Machines Releases Part 2 of Technical Paper Series on Intoxication

Driver Monitoring System technology enables real-time assessment of a driver's functional state relative to the driving environment CANBERRA, Australia, April 21, 2026 /PRNewswire/ -- Seeing Machines Limited, a global leader in vision-based monitoring technology, has released the second part of ...

2026-04-21 14:00 3023

Tuniu Corporation Files Its Annual Report on Form 20-F

NANJING, China, April 20, 2026 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Co...

2026-04-21 11:00 3889

Cadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026

HONG KONG, April 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that positive Phase II results from the COMPASSION-26 study evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, in combination with chemotherapy as first-line treatme...

2026-04-21 10:54 4574

Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile

– RECIST-based ORR of 38.5% (confirmed) and 46.2% (unconfirmed) – mRECIST-based ORR of 61.5% with a complete response (CR) rate of 23% – No Grade 3 or higher adverse events related to RZ-001 observed – Highlights clinical potential of RNA trans-splicing ribozyme platform technology SEOUL, South...

2026-04-21 10:10 3353

1 ... 33 34 353637 38 39 ... 763

Week's Top Stories

Tetra Pak Introduces Industry-first Carton Packaging for Shelf-stable Tuna to Support Southeast Asia's Growing Tuna Industry

[Picked up by 287 media titles]

2026-07-13 10:00

Tetra Pak Introduces Industry-first Carton Packaging for Shelf-stable Tuna to Support Southeast Asia's Growing Tuna Industry

Klook signs an expanded two-year partnership with Korea Tourism Organization

[Picked up by 286 media titles]

2026-07-16 17:49